RU2017120028A - PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HYPERLIPIDIMIA - Google Patents
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HYPERLIPIDIMIA Download PDFInfo
- Publication number
- RU2017120028A RU2017120028A RU2017120028A RU2017120028A RU2017120028A RU 2017120028 A RU2017120028 A RU 2017120028A RU 2017120028 A RU2017120028 A RU 2017120028A RU 2017120028 A RU2017120028 A RU 2017120028A RU 2017120028 A RU2017120028 A RU 2017120028A
- Authority
- RU
- Russia
- Prior art keywords
- lipid
- atorvastatin
- lowering drug
- composition
- glycyrrhizic acid
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims 2
- 239000003524 antilipemic agent Substances 0.000 claims 10
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical class O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims 10
- XUKUURHRXDUEBC-KAYWLYCHSA-N Atorvastatin Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-KAYWLYCHSA-N 0.000 claims 9
- XUKUURHRXDUEBC-UHFFFAOYSA-N Atorvastatin Natural products C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CCC(O)CC(O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-UHFFFAOYSA-N 0.000 claims 9
- 229960005370 atorvastatin Drugs 0.000 claims 9
- 239000000203 mixture Substances 0.000 claims 9
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 claims 8
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 claims 8
- 229960004949 glycyrrhizic acid Drugs 0.000 claims 8
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 claims 8
- 239000001685 glycyrrhizic acid Substances 0.000 claims 8
- 235000019410 glycyrrhizin Nutrition 0.000 claims 8
- ZGGHKIMDNBDHJB-NRFPMOEYSA-M (3R,5S)-fluvastatin sodium Chemical compound [Na+].C12=CC=CC=C2N(C(C)C)C(\C=C\[C@@H](O)C[C@@H](O)CC([O-])=O)=C1C1=CC=C(F)C=C1 ZGGHKIMDNBDHJB-NRFPMOEYSA-M 0.000 claims 2
- PCZOHLXUXFIOCF-UHFFFAOYSA-N Monacolin X Natural products C12C(OC(=O)C(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 PCZOHLXUXFIOCF-UHFFFAOYSA-N 0.000 claims 2
- TUZYXOIXSAXUGO-UHFFFAOYSA-N Pravastatin Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(O)C=C21 TUZYXOIXSAXUGO-UHFFFAOYSA-N 0.000 claims 2
- RYMZZMVNJRMUDD-UHFFFAOYSA-N SJ000286063 Natural products C12C(OC(=O)C(C)(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 RYMZZMVNJRMUDD-UHFFFAOYSA-N 0.000 claims 2
- 229960003765 fluvastatin Drugs 0.000 claims 2
- 229960004844 lovastatin Drugs 0.000 claims 2
- PCZOHLXUXFIOCF-BXMDZJJMSA-N lovastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 PCZOHLXUXFIOCF-BXMDZJJMSA-N 0.000 claims 2
- QLJODMDSTUBWDW-UHFFFAOYSA-N lovastatin hydroxy acid Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(C)C=C21 QLJODMDSTUBWDW-UHFFFAOYSA-N 0.000 claims 2
- 229960002797 pitavastatin Drugs 0.000 claims 2
- VGYFMXBACGZSIL-MCBHFWOFSA-N pitavastatin Chemical compound OC(=O)C[C@H](O)C[C@H](O)\C=C\C1=C(C2CC2)N=C2C=CC=CC2=C1C1=CC=C(F)C=C1 VGYFMXBACGZSIL-MCBHFWOFSA-N 0.000 claims 2
- 229960002965 pravastatin Drugs 0.000 claims 2
- TUZYXOIXSAXUGO-PZAWKZKUSA-N pravastatin Chemical compound C1=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@H]2[C@@H](OC(=O)[C@@H](C)CC)C[C@H](O)C=C21 TUZYXOIXSAXUGO-PZAWKZKUSA-N 0.000 claims 2
- 229960000672 rosuvastatin Drugs 0.000 claims 2
- BPRHUIZQVSMCRT-VEUZHWNKSA-N rosuvastatin Chemical compound CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C=2C=CC(F)=CC=2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(O)=O BPRHUIZQVSMCRT-VEUZHWNKSA-N 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 229960002855 simvastatin Drugs 0.000 claims 2
- RYMZZMVNJRMUDD-HGQWONQESA-N simvastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 RYMZZMVNJRMUDD-HGQWONQESA-N 0.000 claims 2
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Claims (12)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2017120028A RU2683641C2 (en) | 2017-06-07 | 2017-06-07 | Pharmaceutical composition for the treatment of hyperlipidemia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2017120028A RU2683641C2 (en) | 2017-06-07 | 2017-06-07 | Pharmaceutical composition for the treatment of hyperlipidemia |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2014145102A Division RU2623876C2 (en) | 2014-11-10 | 2014-11-10 | Pharmaceutical composition for hyperlipidemia treatment |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2017120028A true RU2017120028A (en) | 2018-12-07 |
| RU2017120028A3 RU2017120028A3 (en) | 2018-12-07 |
| RU2683641C2 RU2683641C2 (en) | 2019-04-01 |
Family
ID=64576930
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2017120028A RU2683641C2 (en) | 2017-06-07 | 2017-06-07 | Pharmaceutical composition for the treatment of hyperlipidemia |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2683641C2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA202090511A1 (en) | 2020-03-13 | 2021-09-30 | ДИКОВСКИЙ, Александр Владимирович | COMPOSITION FOR NORMALIZING BLOOD LIPID LEVELS |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2024546C1 (en) * | 1991-03-04 | 1994-12-15 | Институт органической химии УНЦ РАН | β-GLYCYRRHIZIC ACID GLYCOPEPTIDE WITH L-GLUTAMIC ACID DIBUTYL ETHER SHOWING ANTI-AIDS-ACTIVITY |
| RU2308947C1 (en) * | 2006-02-26 | 2007-10-27 | Новосибирский институт органической химии им. Н.Н. Ворожцова СО РАН (НИОХ СО РАН) | Medicinal agent "simvaglisin" with hypolipidemic effect |
| RU2396079C1 (en) * | 2008-12-03 | 2010-08-10 | Новосибирский институт органической химии им. Н.Н. Ворожцова Сибирского отделения Российской академии наук (НИОХ СО РАН) (статус государственного учреждения) | Hypolipidemic preparation "atorvaglysin" |
| CN103230592A (en) * | 2013-04-07 | 2013-08-07 | 深圳奥萨医药有限公司 | Composition of statin medicine and 5-methyltetrahydrofolic acid, and application thereof |
-
2017
- 2017-06-07 RU RU2017120028A patent/RU2683641C2/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2683641C2 (en) | 2019-04-01 |
| RU2017120028A3 (en) | 2018-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20210082T1 (en) | Methods of preventing cardiovascular events in residual risk dyslipidemic populations | |
| RU2013116807A (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING EPA AND CARDIOVASCULAR MEANS, AND WAYS OF THEIR APPLICATION | |
| JP2015503588A5 (en) | ||
| WO2017083304A8 (en) | Therapeutic compositions for treatment of human immunodeficiency virus | |
| JP2013023499A5 (en) | ||
| FI3562486T3 (en) | Use of sublingual dexmedetomidine for the treatment of agitation | |
| IL292829A (en) | Fixed dose combinations comprising etc1002 and one or more statins for treating or reducing cardiovascular risk | |
| JP2018508551A5 (en) | Fixed dose combination comprising ETC 1002 and one or more statins for treating cardiovascular disease or reducing the risk of cardiovascular disease | |
| JP2016518338A5 (en) | ||
| RU2018144187A (en) | SPECIFIC ANALOGUE OF TRIFFLUORETHYLQUINOLINE FOR USE IN TREATMENT OF APIDS | |
| RU2017120028A (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HYPERLIPIDIMIA | |
| CL2004002030A1 (en) | USE OF INTERFERON AND RIBAVIRINE BECAUSE IT SERVES TO PREPARE A MEDICINAL PRODUCT TO TREAT VIRAL INFECTIONS; PHARMACEUTICAL COMPOSITION THAT INCLUDES INTERFERED, RIBAVIRINE AND OPTIONALLY ANTIOXIDANT; KIT AND ITS USE TO PREPARE A TRAFFICKING MEDICINAL PRODUCT | |
| RU2014145102A (en) | COMBINATION | |
| RU2018110622A (en) | PHARMACEUTICAL COMPOSITION CONTAINING GMG-COA REDUCTASE INHIBITOR AND ACE INHIBITOR | |
| RU2007148908A (en) | COMPOSITIONS FOR REDUCING THE RISK OF ARCTHYME CAUSED BY MEDICINES | |
| EA201400484A1 (en) | TRANSDERMAL MEANS FOR THE TREATMENT AND PREVENTION OF DISEASES OF JOINT AND SOFT TISSUES | |
| RU2016107372A (en) | STRENGTHENING OF METOTREXATE EFFECT BY COMBINED USE WITH LIPOPHILIC STATINS | |
| RU2012136190A (en) | PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF ARTHROZOARTHRITIS CONTAINING REBAMIPID AS AN ACTIVE INGREDIENT | |
| WO2005058310A3 (en) | Use of stating for the treatment of metabolic syndrome | |
| SG11202112796YA (en) | N-containing heteroaryl derivative and pharmaceutical composition comprising same as active ingredient for prevention or treatment of cancer | |
| RU2017129085A (en) | New N-carbamoylmethyl-4-phenyl-2-pyrrolidone formulation | |
| NZ603397A (en) | Association of xanthine oxidase inhibitors and statins and use thereof | |
| RU2020113679A (en) | MEDICINAL COMPOSITION INCLUDING SGLT-2 INHIBITOR AND ANGIOTENSIN RECEPTOR BLOCKER | |
| RU2019134491A (en) | PREVENTION / REDUCTION OF ISCHEMIA-RELATED DAMAGE | |
| WO2020175922A3 (en) | Pharmaceutical composition of single dosage form for treating or preventing hypertension and hyperlipidemia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HE9A | Changing address for correspondence with an applicant | ||
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20201111 |